Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

111
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
111
Wilcoxon Rank-Sum Test01:21

Wilcoxon Rank-Sum Test

124
The Wilcoxon rank-sum test, also known as the Mann-Whitney U test, is a nonparametric test used to determine if there is a significant difference between the distributions of two independent samples. This test is designed specifically for two independent populations and has the following key requirements:
124
Ranks01:02

Ranks

207
Unlike parametric methods, nonparametric statistics are ideal for nominal and ordinal data, requiring fewer assumptions about the population's nature or distribution. This makes nonparametric methods easier to apply and interpret, as they do not depend on parameters like mean or standard deviation. One common approach in nonparametric analysis is to sort data according to a specific criterion. For instance, we might arrange weather data from hottest to coldest days in a month or rank cities...
207
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

92
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
92
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

244
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
244
Bonferroni Test01:10

Bonferroni Test

2.6K
The Bonferroni test is a statistical test named after Carlo Emilio Bonferroni, an Italian mathematician best known for Bonferroni inequalities. This statistical test is a type of multiple comparison test to determine which means are different than the rest. Bonferroni test can minimize the Type 1 error by reducing the significance level alpha, which otherwise increases with sample pairs.
The means of different samples are first paired in all possible combinations.
The null hypothesis of the...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement properties of the interest in health scale among community-dwelling older adults in Japan: Verification of the 12-item, 6-item, and 4-item versions of the interest in health scale.

Preventive medicine reports·2026
Same author

Balloon-occluded Alternative Infusion of Fragmented Gelatin Particles of TACE for Hepatocellular Carcinoma Refractory to Atezolizumab-Bevacizumab.

Anticancer research·2026
Same author

Mid-treatment MRI-based tumor volume reduction rate as a continuous prognostic factor after chemoradiation for cervical cancer: development and two-center internal-external validation.

Journal of radiation research·2026
Same author

Response to "Reconsidering 'photon-ineligible' status in concurrent chemo-proton therapy for stage III non-small cell lung cancer".

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Physicochemical and functional properties of albumin fractions from barley and rye seed protein isolate.

Bioscience, biotechnology, and biochemistry·2026
Same author

Evaluation of tumor detection capability for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm in each MRI sequence.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2026
Same journal

Asymptotic online FWER control for dependent test statistics.

Statistical methods in medical research·2026
Same journal

Regression analysis of misclassified current status data with potentially unknown test accuracy.

Statistical methods in medical research·2026
Same journal

Bayesian multivariate linear mixed-effects models with varied association structures.

Statistical methods in medical research·2026
Same journal

Inference about the ratio of age-standardized rates between two overlapping populations.

Statistical methods in medical research·2026
Same journal

A robust neural network with random effects for subject-specific prediction of clustered count data.

Statistical methods in medical research·2026
Same journal

A comparison of methods for designing hybrid type 2 cluster-randomized trials with continuous effectiveness and implementation endpoints.

Statistical methods in medical research·2026
See all related articles

Related Experiment Video

Updated: May 16, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Permutation-based global rank test with adaptive weights for multiple primary endpoints.

Satoshi Yoshida1,2, Yusuke Yamaguchi3, Kazushi Maruo4

  • 1Data Science, Astellas Pharma Inc., Tokyo, Japan.

Statistical Methods in Medical Research
|May 14, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a novel global rank test for clinical trials with multiple efficacy endpoints. The new method effectively controls the type I error rate and offers improved statistical power, especially with correlated endpoints.

Keywords:
Multiple endpointsglobal testpairwise comparisonpermutation testsmall clinical trial

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K

Related Experiment Videos

Last Updated: May 16, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Analysis

Background:

  • Clinical trials frequently assess multiple efficacy endpoints, necessitating careful selection of primary endpoints for study success.
  • The global test is an emerging statistical approach for analyzing multiple endpoints simultaneously without requiring multiplicity adjustments.
  • Determining appropriate weights for aggregating endpoint statistics is a critical challenge in global test methodology.

Purpose of the Study:

  • To propose a novel global rank test designed to estimate endpoint weights from study data, maximizing the test statistic.
  • To evaluate the type I error rate control and statistical power of the proposed global rank test compared to existing methods.
  • To assess the performance of the proposed test across various scenarios, including different numbers of endpoints and correlation levels.

Main Methods:

  • Development of a novel global rank test that estimates endpoint weights adaptively from the current study data.
  • Utilizing a permutation test to maintain the type I error rate at the nominal level.
  • Conducting simulation studies to compare the proposed test with other global tests under diverse conditions.

Main Results:

  • The proposed global rank test effectively controls the type I error rate across different numbers of primary endpoints and correlation structures.
  • The test demonstrates higher statistical power compared to other global tests when endpoint efficacies vary significantly or when endpoints are moderately correlated (correlation coefficient ≥ 0.5).

Conclusions:

  • The novel global rank test provides a robust and powerful method for analyzing multiple efficacy endpoints in clinical trials.
  • This approach offers advantages in scenarios with heterogeneous endpoint effects or moderate endpoint correlations, enhancing statistical efficiency.